Cargando…

Allogeneic and xenogeneic lymphoid reconstitution in a RAG2(−/−)IL2RG(y/−) severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation

Mice with severe combined immunodeficiency are commonly used as hosts of human cells. Size, longevity, and physiology, however, limit the extent to which immunodeficient mice can model human systems. To address these limitations, we generated RAG2(−/−) IL2RG(y/−) immunodeficient pigs and demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sper, Renan B., Proctor, Jessica, Lascina, Odessa, Guo, Ling, Polkoff, Kathryn, Kaeser, Tobias, Simpson, Sean, Borst, Luke, Gleason, Katherine, Zhang, Xia, Collins, Bruce, Murphy, Yanet, Platt, Jeffrey L., Piedrahita, Jorge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614384/
https://www.ncbi.nlm.nih.gov/pubmed/36311661
http://dx.doi.org/10.3389/fvets.2022.965316
_version_ 1784820191080742912
author Sper, Renan B.
Proctor, Jessica
Lascina, Odessa
Guo, Ling
Polkoff, Kathryn
Kaeser, Tobias
Simpson, Sean
Borst, Luke
Gleason, Katherine
Zhang, Xia
Collins, Bruce
Murphy, Yanet
Platt, Jeffrey L.
Piedrahita, Jorge A.
author_facet Sper, Renan B.
Proctor, Jessica
Lascina, Odessa
Guo, Ling
Polkoff, Kathryn
Kaeser, Tobias
Simpson, Sean
Borst, Luke
Gleason, Katherine
Zhang, Xia
Collins, Bruce
Murphy, Yanet
Platt, Jeffrey L.
Piedrahita, Jorge A.
author_sort Sper, Renan B.
collection PubMed
description Mice with severe combined immunodeficiency are commonly used as hosts of human cells. Size, longevity, and physiology, however, limit the extent to which immunodeficient mice can model human systems. To address these limitations, we generated RAG2(−/−) IL2RG(y/−) immunodeficient pigs and demonstrate successful engraftment of SLA mismatched allogeneic D42 fetal liver cells, tagged with pH2B-eGFP, and human CD34(+) hematopoietic stem cells after in utero cell transplantation. Following intrauterine injection at day 42–45 of gestation, fetuses were allowed to gestate to term and analyzed postnatally for the presence of pig (allogeneic) and human (xenogeneic) B cells, T-cells and NK cells in peripheral blood and other lymphoid tissues. Engraftment of allogeneic hematopoietic cells was detected based on co-expression of pH2B-eGFP and various markers of differentiation. Analysis of spleen revealed robust generation and engraftment of pH2B-eGFP mature B cells (and IgH recombination) and mature T-cells (and TCR-β recombination), T helper (CD3(+)CD4(+)) and T cytotoxic (CD3(+)CD8(+)) cells. The thymus revealed engraftment of pH2B-eGFP double negative precursors (CD4(−)CD8(−)) as well as double positive (CD4(+), CD8(+)) precursors and single positive T-cells. After intrauterine administration of human CD34(+) hematopoietic stem cells, analysis of peripheral blood and lymphoid tissues revealed the presence of human T-cells (CD3(+)CD4(+) and CD3(+)CD8(+)) but no detectable B cells or NK cells. The frequency of human CD45(+) cells in the circulation decreased rapidly and were undetectable within 2 weeks of age. The frequency of human CD45(+) cells in the spleen also decreased rapidly, becoming undetectable at 3 weeks. In contrast, human CD45(+)CD3(+) T-cells comprised >70% of cells in the pig thymus at birth and persisted at the same frequency at 3 weeks. Most human CD3(+) cells in the pig's thymus expressed CD4 or CD8, but few cells were double positive (CD4(+) CD8(+)). In addition, human CD3(+) cells in the pig thymus contained human T-cell excision circles (TREC), suggesting de novo development. Our data shows that the pig thymus provides a microenvironment conducive to engraftment, survival and development of human T-cells and provide evidence that the developing T-cell compartment can be populated to a significant extent by human cells in large animals.
format Online
Article
Text
id pubmed-9614384
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96143842022-10-29 Allogeneic and xenogeneic lymphoid reconstitution in a RAG2(−/−)IL2RG(y/−) severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation Sper, Renan B. Proctor, Jessica Lascina, Odessa Guo, Ling Polkoff, Kathryn Kaeser, Tobias Simpson, Sean Borst, Luke Gleason, Katherine Zhang, Xia Collins, Bruce Murphy, Yanet Platt, Jeffrey L. Piedrahita, Jorge A. Front Vet Sci Veterinary Science Mice with severe combined immunodeficiency are commonly used as hosts of human cells. Size, longevity, and physiology, however, limit the extent to which immunodeficient mice can model human systems. To address these limitations, we generated RAG2(−/−) IL2RG(y/−) immunodeficient pigs and demonstrate successful engraftment of SLA mismatched allogeneic D42 fetal liver cells, tagged with pH2B-eGFP, and human CD34(+) hematopoietic stem cells after in utero cell transplantation. Following intrauterine injection at day 42–45 of gestation, fetuses were allowed to gestate to term and analyzed postnatally for the presence of pig (allogeneic) and human (xenogeneic) B cells, T-cells and NK cells in peripheral blood and other lymphoid tissues. Engraftment of allogeneic hematopoietic cells was detected based on co-expression of pH2B-eGFP and various markers of differentiation. Analysis of spleen revealed robust generation and engraftment of pH2B-eGFP mature B cells (and IgH recombination) and mature T-cells (and TCR-β recombination), T helper (CD3(+)CD4(+)) and T cytotoxic (CD3(+)CD8(+)) cells. The thymus revealed engraftment of pH2B-eGFP double negative precursors (CD4(−)CD8(−)) as well as double positive (CD4(+), CD8(+)) precursors and single positive T-cells. After intrauterine administration of human CD34(+) hematopoietic stem cells, analysis of peripheral blood and lymphoid tissues revealed the presence of human T-cells (CD3(+)CD4(+) and CD3(+)CD8(+)) but no detectable B cells or NK cells. The frequency of human CD45(+) cells in the circulation decreased rapidly and were undetectable within 2 weeks of age. The frequency of human CD45(+) cells in the spleen also decreased rapidly, becoming undetectable at 3 weeks. In contrast, human CD45(+)CD3(+) T-cells comprised >70% of cells in the pig thymus at birth and persisted at the same frequency at 3 weeks. Most human CD3(+) cells in the pig's thymus expressed CD4 or CD8, but few cells were double positive (CD4(+) CD8(+)). In addition, human CD3(+) cells in the pig thymus contained human T-cell excision circles (TREC), suggesting de novo development. Our data shows that the pig thymus provides a microenvironment conducive to engraftment, survival and development of human T-cells and provide evidence that the developing T-cell compartment can be populated to a significant extent by human cells in large animals. Frontiers Media S.A. 2022-10-14 /pmc/articles/PMC9614384/ /pubmed/36311661 http://dx.doi.org/10.3389/fvets.2022.965316 Text en Copyright © 2022 Sper, Proctor, Lascina, Guo, Polkoff, Kaeser, Simpson, Borst, Gleason, Zhang, Collins, Murphy, Platt and Piedrahita. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Sper, Renan B.
Proctor, Jessica
Lascina, Odessa
Guo, Ling
Polkoff, Kathryn
Kaeser, Tobias
Simpson, Sean
Borst, Luke
Gleason, Katherine
Zhang, Xia
Collins, Bruce
Murphy, Yanet
Platt, Jeffrey L.
Piedrahita, Jorge A.
Allogeneic and xenogeneic lymphoid reconstitution in a RAG2(−/−)IL2RG(y/−) severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation
title Allogeneic and xenogeneic lymphoid reconstitution in a RAG2(−/−)IL2RG(y/−) severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation
title_full Allogeneic and xenogeneic lymphoid reconstitution in a RAG2(−/−)IL2RG(y/−) severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation
title_fullStr Allogeneic and xenogeneic lymphoid reconstitution in a RAG2(−/−)IL2RG(y/−) severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation
title_full_unstemmed Allogeneic and xenogeneic lymphoid reconstitution in a RAG2(−/−)IL2RG(y/−) severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation
title_short Allogeneic and xenogeneic lymphoid reconstitution in a RAG2(−/−)IL2RG(y/−) severe combined immunodeficient pig: A preclinical model for intrauterine hematopoietic transplantation
title_sort allogeneic and xenogeneic lymphoid reconstitution in a rag2(−/−)il2rg(y/−) severe combined immunodeficient pig: a preclinical model for intrauterine hematopoietic transplantation
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614384/
https://www.ncbi.nlm.nih.gov/pubmed/36311661
http://dx.doi.org/10.3389/fvets.2022.965316
work_keys_str_mv AT sperrenanb allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT proctorjessica allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT lascinaodessa allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT guoling allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT polkoffkathryn allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT kaesertobias allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT simpsonsean allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT borstluke allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT gleasonkatherine allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT zhangxia allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT collinsbruce allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT murphyyanet allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT plattjeffreyl allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation
AT piedrahitajorgea allogeneicandxenogeneiclymphoidreconstitutioninarag2il2rgyseverecombinedimmunodeficientpigapreclinicalmodelforintrauterinehematopoietictransplantation